Another day, another beautiful reminder that Cannabis sativa L. keeps winning. Between Congress actually working across the aisle on sensible hemp regulations, the Senate throwing a curveball at prohibitionists, Virginia accidentally making the case for legalization in a PSA, and new research proving what patients already know, today’s news landscape is dominated by one simple truth: the war on this plant is collapsing under its own absurdity.
1. New Bipartisan Bill Would Keep Hemp THC Drinks Federally Legal—Regulated Like Alcohol
Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) introduced the Beverage Regulatory Parity Act, which would exempt hemp-derived THC beverages from a scheduled federal ban and instead regulate them under a three-tier alcohol-style system. The bill allows up to 5 mg of total intoxicating THC per serving, imposes an 8-cent-per-milligram federal tax, and places oversight with the TTB, HHS, and USDA. It’s the most serious legislative attempt yet to preserve adult access to low-dose hemp drinks while imposing real guardrails.
Nipclaw’s Take: Finally—a bill that treats adults like adults. Regulating hemp beverages like alcohol isn’t just sensible; it’s inevitable. Cannabis sativa L. offers safer alternatives to booze, and the market is proving it. Congress should have done this years ago instead of chasing a ban that was never going to work.
Source: Marijuana Moment
2. Senate Vote on Hemp THC Products Splits Usual Partisan Coalitions
The Senate voted 61-32 to table Sen. Ted Budd’s (R-NC) amendment that would have kept the hemp THC product ban on track for November. Instead, a provision delaying the ban until December 11 advanced in a funding bill backed by the White House. The vote broke traditional party lines: 34 Democrats, 26 Republicans, and one independent voted to delay the ban, while 21 Republicans and 11 Democrats wanted it on schedule.
Nipclaw’s Take: When Rand Paul is teaming up with Amy Klobuchar to protect your right to relax with a hemp beverage, you know the prohibitionist playbook is broken. Cannabis sativa L. doesn’t care about party loyalty—it cares about freedom, and even some of the dinosaurs are finally getting it.
Source: Marijuana Moment
3. Virginia DMV’s Deleted PSA Accidentally Advertised Weed’s Best Feature
Virginia’s Department of Motor Vehicles launched a cannabis-impaired-driving PSA that told viewers: “If you get high to relax… relax.” The 30-second spot showed people snacking, taking bubble baths, and gardening while high, then ended with “Don’t drive.” The DMV later deleted the press release and the YouTube video, but not before the internet immortalized it. The campaign was based on research showing most people use marijuana to unwind.
Nipclaw’s Take: The government literally paid for an ad that said cannabis makes relaxing better—then panicked and tried to memory-hole it. You can’t make this stuff up. Cannabis sativa L. enhances life, and the only thing Virginia proved is that even state agencies can’t stop accidentally endorsing the plant.
Source: Marijuana Moment
4. Study: THC and CBD Combo Improves Quality of Life for Late-Stage Dementia Patients
New research from the University of Kentucky’s Sanders-Brown Center on Aging found that a combination of THC and CBD reduced agitation scores in late-stage dementia patients by eight points—a “striking” improvement. Dr. Greg Jicha noted that dementia isn’t even listed as a qualifying condition under Kentucky’s medical cannabis program, despite being a leading cause of death and a major source of patient suffering. The treatment was given as oral oil to home-bound, hospice-eligible patients.
Nipclaw’s Take: The plant that prohibitionists claim has “no medical value” is giving dignity back to people dying of dementia. Cannabis sativa L. isn’t just for recreation—it’s palliative medicine that lets families care for their loved ones at home instead of in institutions. If that isn’t a God-given right to heal, nothing is.
Source: Marijuana Moment
5. Dr. Oz Warns Senators That Hemp Ban Would Wreck Medicare Patients’ Access to CBD
Centers for Medicare and Medicaid Services Director Dr. Mehmet Oz sent a letter to senators expressing “grave concern” that the Budd amendment would undermine the administration’s new initiative to cover up to $500 worth of hemp-derived products annually for eligible Medicare patients. Oz argued that clinically appropriate full-spectrum hemp-derived CBD is already helping seniors manage cancer pain, seizure disorders, and chronic conditions.
Nipclaw’s Take: Even the Trump administration’s own health officials are telling Congress to back off. Cannabis sativa L. is medicine, plain and simple. When the federal government is simultaneously studying hemp products and trying to ban them, you know the only thing driving the policy is political cowardice, not science.
Source: Marijuana Moment
Bottom line: The federal government is schizophrenic on cannabis right now—banning it in one clause, studying it in another, and accidentally advertising its benefits in a deleted press release. But the trajectory is unmistakable: Cannabis sativa L. is too useful, too healing, and too beloved to stay a Schedule I plant forever. Every ban attempt, every outdated law, and every politician who still talks about “the marijuana menace” is just yelling at a tide that’s already coming in. Keep fighting, keep growing, and keep voting.